{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:00:10Z","timestamp":1772136010758,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ETH Zurich Postdoctoral Fellowship and Marie Curie Actions for People COFUND program"},{"name":"Royal Society of Chemistry mobility grant"},{"name":"ETH Zurich Postdoctoral Fellowship and Marie Curie Actions for People COFUND program Royal Society of Chemistry mobility grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Phenylketonuria is a genetic disorder affecting the metabolism of phenylalanine (phe) due to a deficiency in the enzyme phenylalanine hydroxylase. This disorder is characterized by an elevated phe blood level, which can lead to severe intellectual disabilities in newborns. The current strategy to prevent these devastating consequences is limited to a life-long phe-free diet, which implies major lifestyle changes and restrictions. Recently, an injectable enzyme replacement therapy, Pegvaliase, has been approved for treating phenylketonuria, but is associated with significant side-effects. In this study a phe-metabolizing system suitable for oral delivery is designed to overcome the need for daily injections. Active phenylalanine ammonia-lyase (PAL), an enzyme that catalyses phe metabolism, is loaded into mesoporous silica microparticles (MSP) with pore sizes ranging from 10 to 35\u2009nm. The surface of the MSP is lined with a semipermeable barrier to allow permeation of phe while blocking digestive enzymes that degrade PAL. The enzymatic activity can be partially preserved\n                    <jats:italic>in vitro<\/jats:italic>\n                    by coating the MSP with poly(allylamine) and poly(acrylic acid)-bowman birk (protease inhibitor) conjugate. The carrier system presented herein may provide a general approach to overcome gastro-intestinal proteolytic digestion and to deliver active enzymes to the intestinal lumen for prolonged local action.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-60463-y","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T06:04:32Z","timestamp":1582783472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: phenylalanine ammonia lyase as case study"],"prefix":"10.1038","volume":"10","author":[{"given":"Irene","family":"Pereira de Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Gourmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olena","family":"Berkovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-1292","authenticated-orcid":false,"given":"Jean-Christophe","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"60463_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg, A. M. J. et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J. Rare Dis. 12, 162, https:\/\/doi.org\/10.1186\/s13023-017-0685-2 (2017).","journal-title":"Orphanet J. Rare Dis."},{"key":"60463_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau, N., van Spronsen, F. J. & Levy, H. L. Phenylketonuria. Lancet 376, 1417\u20131427, https:\/\/doi.org\/10.1016\/S0140-6736(10)60961-0 (2010).","journal-title":"Lancet"},{"key":"60463_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2017.01.001","volume":"120","author":"ER Jurecki","year":"2017","unstructured":"Jurecki, E. R. et al. Adherence to clinic recommendations among patients with phenylketonuria in the United States. Mol. Genet. Metab. 120, 190\u2013197, https:\/\/doi.org\/10.1016\/j.ymgme.2017.01.001 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"60463_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(02)09334-0","volume":"360","author":"JH Walter","year":"2002","unstructured":"Walter, J. H. et al. How practical are recommendations for dietary control in phenylketonuria? Lancet 360, 55\u201357, https:\/\/doi.org\/10.1016\/S0140-6736(02)09334-0 (2002).","journal-title":"Lancet"},{"key":"60463_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1517\/14656566.2015.1013030","volume":"16","author":"N Blau","year":"2015","unstructured":"Blau, N. & Longo, N. Alternative therapies to address the unmet medical needs of patients with phenylketonuria. Expert Opin. on Pharmacother 16, 791\u2013800, https:\/\/doi.org\/10.1517\/14656566.2015.1013030 (2015).","journal-title":"Expert Opin. on Pharmacother"},{"key":"60463_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jpeds.2007.02.017","volume":"150","author":"B Fiege","year":"2007","unstructured":"Fiege, B. & Blau, N. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria. J. Pediatr. 150, 627\u2013630, https:\/\/doi.org\/10.1016\/j.jpeds.2007.02.017 (2007).","journal-title":"J. Pediatr."},{"key":"60463_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","volume":"16","author":"J Vockley","year":"2014","unstructured":"Vockley, J. et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet. Med. 16, 188\u2013200, https:\/\/doi.org\/10.1038\/gim.2013.157 (2014).","journal-title":"Genet. Med."},{"key":"60463_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s40259-018-0292-3","volume":"32","author":"A Markham","year":"2018","unstructured":"Markham, A. Pegvaliase: First Global Approval. BioDrugs 32, 391\u2013395, https:\/\/doi.org\/10.1007\/s40259-018-0292-3 (2018).","journal-title":"BioDrugs"},{"key":"60463_CR9","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1073\/pnas.96.5.2339","volume":"96","author":"CN Sarkissian","year":"1999","unstructured":"Sarkissian, C. N. et al. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. PNAS 96, 2339\u20132344, https:\/\/doi.org\/10.1073\/pnas.96.5.2339 (1999).","journal-title":"PNAS"},{"key":"60463_CR10","doi-asserted-by":"publisher","first-page":"20894","DOI":"10.1073\/pnas.0808421105","volume":"105","author":"CN Sarkissian","year":"2008","unstructured":"Sarkissian, C. N. et al. Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria. PNAS 105, 20894\u201320899, https:\/\/doi.org\/10.1073\/pnas.0808421105 (2008).","journal-title":"PNAS"},{"key":"60463_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jconrel.2014.08.004","volume":"192","author":"I Pereira de Sousa","year":"2014","unstructured":"Pereira de Sousa, I. & Bernkop-Schnurch, A. Pre-systemic metabolism of orally administered drugs and strategies to overcome it. J. Control. Release 192, 301\u2013309, https:\/\/doi.org\/10.1016\/j.jconrel.2014.08.004 (2014).","journal-title":"J. Control. Release"},{"key":"60463_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1042\/bj1990715","volume":"199","author":"HJ Gilbert","year":"1981","unstructured":"Gilbert, H. J. & Jack, G. W. The effect of proteinases on phenylalanine ammonia-lyase from the yeast Rhodotorula glutinis. Biochem. J. 199, 715\u2013723, https:\/\/doi.org\/10.1042\/bj1990715 (1981).","journal-title":"Biochem. J"},{"key":"60463_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0014-5793(85)80219-2","volume":"180","author":"L Bourget","year":"1985","unstructured":"Bourget, L. & Chang, T. M. Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria. FEBS Lett. 180, 5\u20138, https:\/\/doi.org\/10.1016\/0014-5793(85)80219-2 (1985).","journal-title":"FEBS Lett"},{"key":"60463_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/0304-4165(86)90281-3","volume":"883","author":"L Bourget","year":"1986","unstructured":"Bourget, L. & Chang, T. M. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model. Biochim. Biophys. Acta 883, 432\u2013438, https:\/\/doi.org\/10.1016\/0304-4165(86)90281-3 (1986).","journal-title":"Biochim. Biophys. Acta"},{"key":"60463_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ymgme.2011.06.016","volume":"104","author":"CN Sarkissian","year":"2011","unstructured":"Sarkissian, C. N., Kang, T. S., Gamez, A., Scriver, C. R. & Stevens, R. C. Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria. Mol. Genet. Metab. 104, 249\u2013254, https:\/\/doi.org\/10.1016\/j.ymgme.2011.06.016 (2011).","journal-title":"Mol. Genet. Metab."},{"key":"60463_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2009.09.002","volume":"99","author":"TS Kang","year":"2010","unstructured":"Kang, T. S. et al. Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria. Mol. Genet. Metab. 99, 4\u20139, https:\/\/doi.org\/10.1016\/j.ymgme.2009.09.002 (2010).","journal-title":"Mol. Genet. Metab."},{"key":"60463_CR17","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1002\/anie.201208840","volume":"52","author":"R Guillet-Nicolas","year":"2013","unstructured":"Guillet-Nicolas, R. et al. pH-responsive nutraceutical-mesoporous silica nanoconjugates with enhanced colloidal stability. Angew. Chem. 52, 2318\u20132322, https:\/\/doi.org\/10.1002\/anie.201208840 (2013).","journal-title":"Angew. Chem."},{"key":"60463_CR18","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1039\/c4cc00620h","volume":"50","author":"A Popat","year":"2014","unstructured":"Popat, A. et al. Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery. Chem. Commun. 50, 5547\u20135550, https:\/\/doi.org\/10.1039\/c4cc00620h (2014).","journal-title":"Chem. Commun."},{"key":"60463_CR19","doi-asserted-by":"publisher","first-page":"505605","DOI":"10.1088\/0957-4484\/27\/50\/505605","volume":"27","author":"SB Hartono","year":"2016","unstructured":"Hartono, S. B. et al. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement. Nanotechnology 27, 505605, https:\/\/doi.org\/10.1088\/0957-4484\/27\/50\/505605 (2016).","journal-title":"Nanotechnology"},{"key":"60463_CR20","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1039\/B511346F","volume":"15","author":"PF Fulvio","year":"2005","unstructured":"Fulvio, P. F., Pikus, S. & Jaroniec, M. Tailoring properties of SBA-15 materials by controlling conditions of hydrothermal synthesis. J. Mater. Chem. 15, 5049\u20135053, https:\/\/doi.org\/10.1039\/B511346F (2005).","journal-title":"J. Mater. Chem."},{"key":"60463_CR21","doi-asserted-by":"publisher","first-page":"e0173269","DOI":"10.1371\/journal.pone.0173269","volume":"12","author":"SM Bell","year":"2017","unstructured":"Bell, S. M. et al. Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria. PLoS One 12, e0173269, https:\/\/doi.org\/10.1371\/journal.pone.0173269 (2017).","journal-title":"PLoS One"},{"key":"60463_CR22","doi-asserted-by":"publisher","first-page":"e108586","DOI":"10.1371\/journal.pone.0108586","volume":"9","author":"L Zhu","year":"2014","unstructured":"Zhu, L. et al. Efficient preparation of enantiopure D-phenylalanine through asymmetric resolution using immobilized phenylalanine ammonia-lyase from Rhodotorula glutinis JN-1 in a recirculating packed-bed reactor. PLoS One 9, e108586, https:\/\/doi.org\/10.1371\/journal.pone.0108586 (2014).","journal-title":"PLoS One"},{"key":"60463_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1139\/o07-018","volume":"85","author":"MJ MacDonald","year":"2007","unstructured":"MacDonald, M. J. & D\u2019Cunha, G. B. A modern view of phenylalanine ammonia lyase. Biochem. Cell Biol. 85, 273\u2013282, https:\/\/doi.org\/10.1139\/o07-018 (2007).","journal-title":"Biochem. Cell Biol."},{"key":"60463_CR24","doi-asserted-by":"publisher","first-page":"32211","DOI":"10.1021\/acsami.6b11324","volume":"8","author":"J Tu","year":"2016","unstructured":"Tu, J. et al. Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation and Release of Proteins. ACS Appl. Mater. Interfaces 8, 32211\u201332219, https:\/\/doi.org\/10.1021\/acsami.6b11324 (2016).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"60463_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3109\/07388551.2013.791660","volume":"34","author":"JD Cui","year":"2014","unstructured":"Cui, J. D., Qiu, J. Q., Fan, X. W., Jia, S. R. & Tan, Z. L. Biotechnological production and applications of microbial phenylalanine ammonia lyase: a recent review. Crit. Rev. Biotechnol. 34, 258\u2013268, https:\/\/doi.org\/10.3109\/07388551.2013.791660 (2014).","journal-title":"Crit. Rev. Biotechnol."},{"key":"60463_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","volume":"52","author":"A Bernkop-Schnurch","year":"1998","unstructured":"Bernkop-Schnurch, A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Control. Release 52, 1\u201316, https:\/\/doi.org\/10.1016\/S0168-3659(97)00204-6 (1998).","journal-title":"J. Control. Release"},{"key":"60463_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/10408390601177589","volume":"48","author":"JN Losso","year":"2008","unstructured":"Losso, J. N. The biochemical and functional food properties of the bowman-birk inhibitor. Crit. Rev. Food Sci. Nutr. 48, 94\u2013118, https:\/\/doi.org\/10.1080\/10408390601177589 (2008).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"60463_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10731199509117665","volume":"23","author":"TM Chang","year":"1995","unstructured":"Chang, T. M., Bourget, L. & Lister, C. A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzymeartificial cells, as in removing phenylalanine in phenylketonuria. Artif. Cells Blood Substit. Biotechnol. 23, 1\u201321, https:\/\/doi.org\/10.3109\/10731199509117665 (1995).","journal-title":"Artif. Cells Blood Substit. Biotechnol."},{"issue":"9","key":"60463_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"Vincent M Isabella","year":"2018","unstructured":"Isabella, V. M. et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat. Biotechnol. 36, 857, https:\/\/doi.org\/10.1038\/nbt.4222, https:\/\/www.nature.com\/articles\/nbt.4222#supplementary-information (2018).","journal-title":"Nature Biotechnology"},{"key":"60463_CR30","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s11095-013-1233-y","volume":"31","author":"G Fuhrmann","year":"2014","unstructured":"Fuhrmann, G. & Leroux, J. C. Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives. Pharm Res 31, 1099\u20131105, https:\/\/doi.org\/10.1007\/s11095-013-1233-y (2014).","journal-title":"Pharm Res"},{"key":"60463_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/adma.201504797","volume":"28","author":"JD Schulz","year":"2016","unstructured":"Schulz, J. D. et al. Site-Specific Polymer Conjugation Stabilizes Therapeutic Enzymes in the Gastrointestinal Tract. Adv. Mater. 28, 1455\u20131460, https:\/\/doi.org\/10.1002\/adma.201504797 (2016).","journal-title":"Adv. Mater."},{"key":"60463_CR32","doi-asserted-by":"publisher","unstructured":"Carlsson, N. et al. Enzymes immobilized in mesoporous silica: A physical\u2013chemical perspective. Adv. Colloid Interface Sci. 205, 339\u2013360, https:\/\/doi.org\/10.1038\/s41598-020-60463-y","DOI":"10.1038\/s41598-020-60463-y"},{"key":"60463_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0169-409X(98)00043-X","volume":"34","author":"TH Ermak","year":"1998","unstructured":"Ermak, T. H. & Giannasca, P. J. Microparticle targeting to M cells. Adv. Drug Del. Rev 34, 261\u2013283, https:\/\/doi.org\/10.1016\/S0169-409X(98)00043-X (1998).","journal-title":"Adv. Drug Del. Rev"},{"key":"60463_CR34","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/smll.201000379","volume":"6","author":"AL Becker","year":"2010","unstructured":"Becker, A. L., Johnston, A. P. & Caruso, F. Layer-by-layer-assembled capsules and films for therapeutic delivery. Small 6, 1836\u20131852, https:\/\/doi.org\/10.1002\/smll.201000379 (2010).","journal-title":"Small"},{"key":"60463_CR35","doi-asserted-by":"publisher","first-page":"1602066","DOI":"10.1002\/smll.201602066","volume":"13","author":"A Polomska","year":"2017","unstructured":"Polomska, A., Gauthier, M. A. & Leroux, J.-C. In Vitro and In Vivo Evaluation of PEGylated Layer-by-Layer Polyelectrolyte-Coated Paclitaxel Nanocrystals. Small 13, 1602066, https:\/\/doi.org\/10.1002\/smll.201602066 (2017).","journal-title":"Small"},{"key":"60463_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-5173(98)00027-1","volume":"166","author":"P He","year":"1998","unstructured":"He, P., Davis, S. S. & Illum, L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166, 75\u201388, https:\/\/doi.org\/10.1016\/S0378-5173(98)00027-1 (1998).","journal-title":"Int. J. Pharm."},{"key":"60463_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1399-3011.1985.tb02155.x","volume":"25","author":"Y Birk","year":"1985","unstructured":"Birk, Y. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans. Int. J. Pept. Protein Res 25, 113\u2013131, https:\/\/doi.org\/10.1111\/j.1399-3011.1985.tb02155.x (1985).","journal-title":"Int. J. Pept. Protein Res"},{"key":"60463_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/bf01092196","volume":"35","author":"JJ Rackis","year":"1985","unstructured":"Rackis, J. J., Gumbmann, M. R. & Liener, I. E. The USDA trypsin inhibitor study. I. Background, objectives, and procedural details. Plant Foods Hum. Nutr. 35, 213\u2013242, https:\/\/doi.org\/10.1007\/bf01092196 (1985).","journal-title":"Plant Foods Hum. Nutr."},{"key":"60463_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpharm.2015.02.055","volume":"484","author":"F Yu","year":"2015","unstructured":"Yu, F. et al. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Int. J. Pharm. 484, 181\u2013191, https:\/\/doi.org\/10.1016\/j.ijpharm.2015.02.055 (2015).","journal-title":"Int. J. Pharm."},{"key":"60463_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1021\/acs.chemrev.6b00824","volume":"118","author":"F Parmeggiani","year":"2018","unstructured":"Parmeggiani, F., Weise, N. J., Ahmed, S. T. & Turner, N. J. Synthetic and Therapeutic Applications of Ammonia-lyases and Aminomutases. Chem. Rev. 118, 73\u2013118, https:\/\/doi.org\/10.1021\/acs.chemrev.6b00824 (2018).","journal-title":"Chem. Rev."},{"key":"60463_CR41","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1088\/0957-4484\/17\/22\/001","volume":"17","author":"L Chenghong","year":"2006","unstructured":"Chenghong, L. et al. Characterization of functionalized nanoporous supports for protein confinement. Nanotechnology 17, 5531, https:\/\/doi.org\/10.1088\/0957-4484\/17\/22\/001 (2006).","journal-title":"Nanotechnology"},{"key":"60463_CR42","doi-asserted-by":"publisher","first-page":"21264","DOI":"10.1021\/jp206976d","volume":"115","author":"L Wang","year":"2011","unstructured":"Wang, L. & Yang, R. T. Increasing Selective CO2 Adsorption on Amine-Grafted SBA-15 by Increasing Silanol Density. J. Phys. Chem. C 115, 21264\u201321272, https:\/\/doi.org\/10.1021\/jp206976d (2011).","journal-title":"J. Phys. Chem. C"},{"key":"60463_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0142-9612(94)90054-X","volume":"15","author":"SE Kakabakos","year":"1994","unstructured":"Kakabakos, S. E., Tyllianakis, P. E., Evangelatos, G. P. & Ithakissios, D. S. Colorimetric determination of reactive solid-supported primary and secondary amino groups. Biomaterials 15, 289\u2013297, https:\/\/doi.org\/10.1016\/0142-9612(94)90054-X (1994).","journal-title":"Biomaterials"},{"key":"60463_CR44","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/1841296b0","volume":"184","author":"BHJ Hofstee","year":"1959","unstructured":"Hofstee, B. H. J. Non-Inverted Versus Inverted Plots in Enzyme Kinetics. Nature 184, 1296\u20131298, https:\/\/doi.org\/10.1038\/1841296b0 (1959).","journal-title":"Nature"},{"key":"60463_CR45","doi-asserted-by":"publisher","first-page":"7663","DOI":"10.1021\/la2015034","volume":"27","author":"V Thilakarathne","year":"2011","unstructured":"Thilakarathne, V., Briand, V. A., Zhou, Y., Kasi, R. M. & Kumar, C. V. Protein polymer conjugates: improving the stability of hemoglobin with poly(acrylic acid). Langmuir 27, 7663\u20137671, https:\/\/doi.org\/10.1021\/la2015034 (2011).","journal-title":"Langmuir"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60463-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60463-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60463-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:25:23Z","timestamp":1670293523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60463-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60463"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60463-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/638130","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"21 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3651"}}